Delivery Order SPE2DB20D3103-SPE2DB23FP8U3

Award Date 9/26/23
Potential Completion Date 9/27/23
Potential Value $1.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of TELMISARTAN 40 MG TABLET 30S. The contract has a ceiling value of $3,554.38 and a completion date of October 24, 2023. It is a firm fixed-price delivery order contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $6,699.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4560607919 - TELMISARTAN 20 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of April 18, 2023 and is a Firm Fixed Price Delivery Order. The contract was awarded on a full and open competition basis, with no set-aside designation. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,145.02, is for the delivery of TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of December 28, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award, valued at $4,103.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4560923528 - TELMISARTAN 40 MG TABLET 30S. The contract has a period of performance through May 15, 2023 and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award, valued at $1,363.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Telmisartan 40 mg tablets to support military and government healthcare programs. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of November 17, 2023. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $1,470.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication, to support federal healthcare programs. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a $1,381.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication, to support military healthcare programs and federal medical institutions. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,980.18 firm fixed-price contract is for the supply of TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of January 6, 2025. This Delivery Order is issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,674.67, is a delivery order for the supply of 4565040739 - TELMISARTAN 40 MG TABLET 30S. The contract has an ultimate completion date of July 2, 2024 and is a firm fixed price contract. Amerisourcebergen Drug Corp is the prime contractor and there is no indication of any set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Telmisartan 40 mg tablets. The contract, valued at $31,017.60, is a firm fixed-price delivery order with a completion date of September 1, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FP8U3
    Delivery Order

This federal contract award, valued at $1,371.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TELMISARTAN 40 MG TABLET 30S, a pharmaceutical product, with a completion date of September 27, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it was awarded on September 26, 2023. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally.

Generated 5/12/25, 10:23 AM